Data Protection - Perú

Authors

  • Maritza Reátegui Valdiviezo

Keywords:

data protection, Data exclusivity, clinical studies, Pharmaceutical Law, Pharmaceutical products

Abstract

The present article refers to the implementation of the Protection of Testing Data for
pharmaceutical products in the light of the implementation of the FTA signed by Peru
and the United States of America and the application of the definitions given by the
TRIPS for this figure. The national legislation and the applicable treaties are analyzed
as well as the first cases of protection to the new chemical entities given by the regulatory
authority. The successes and drawbacks of the new Testing Data legislation. Their
impact on heath and research issues.

Downloads

Download data is not yet available.

Author Biography

  • Maritza Reátegui Valdiviezo

    Catedrática Universitaria y expositora nacional e internacional en temas de propiedad intelectual y
    Derecho Farmacéutico. Es Socia del Estudio Muñiz, Ramírez, Pérez – Taiman & Olaya Abogados

References

Downloads

Published

30.11.2019

Issue

Vol. 13 No. 1 (2012): Revista de Derecho

Section

DOCTRINA NACIONAL

License

This jounal and its articles are published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license, whereby the user is free to: share, copy and redistribute the material in any medium or format, as long as: give credit appropriately, provide a link to the license and indicate if changes have been made; do not use our content for commercial purposes; and / or remix or transform the material. 

How to Cite

Reátegui Valdiviezo, M. (2019). Data Protection - Perú. Revista De Derecho, 13(1), 115-146. https://revistadecomunicacion.com/index.php/derecho/article/view/1624